Lin-Shiau S Y, Hammonds R G, Li C H
Eur J Pharmacol. 1983 Feb 18;87(2-3):297-300. doi: 10.1016/0014-2999(83)90341-2.
Binding of human beta-endorphin to mouse brain membrane preparations has been characterized using the tritiated hormone as primary ligand. The binding was shown to be time and temperature dependent. The dissociation constant of the saturable binding was determined to be 0.5 nM. Both [Met5]enkephalin and naloxone were found to compete with tritiated beta-endorphin for the binding with a potency of 6.3 and 6.5% of the unlabeled hormone, respectively. Phospholipase A2 isolated from Formosan cobra venom was shown to be a potent inhibitor of the binding with a 50% inhibition concentration of 26 nM. Although Na+, K+, Ca2+, Mg2+ were found individually to exert a profound inhibition on the binding, the combined salt solution (Tyrode) did not abolish the specific binding of tritiated beta-endorphin to the mouse brain membrane preparations.
利用氚标记的人β-内啡肽作为主要配体,对其与小鼠脑膜制剂的结合特性进行了表征。结果表明,这种结合具有时间和温度依赖性。可饱和结合的解离常数测定为0.5 nM。发现[Met5]脑啡肽和纳洛酮均与氚标记的β-内啡肽竞争结合,其效力分别为未标记激素的6.3%和6.5%。从台湾眼镜蛇毒液中分离出的磷脂酶A2被证明是一种有效的结合抑制剂,其50%抑制浓度为26 nM。尽管分别发现Na+、K+、Ca2+、Mg2+对结合有显著抑制作用,但混合盐溶液(台氏液)并未消除氚标记的β-内啡肽与小鼠脑膜制剂的特异性结合。